Key points are not available for this paper at this time.
Straightforward access toward previously unreported substituted, heterocyclic spiro3.3heptanes is disclosed. These spirocyclic systems may be considered as alternatives to 1,3-heteroatom-substituted cyclohexanes, which are otherwise insufficiently stable to allow their use in drug discovery. Conformational details are discussed on the basis of X-ray crystallographic structures.
Burkhard et al. (Wed,) studied this question.